The Latest Breaking News from Abbott

Medtronic, battered by a high number of serious medical device recalls in recent years, says it is toughening its internal assessments for acquiring new products.

American health-care giant cites shrinking market share amid stiff competition but will expand other businesses including diagnostics, devices and pharmaceuticals

Academy of Nutrition and Dietetics has a record of quid pro quos with a range of food giants, documents show

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn’t been going out long when she laid down the law: He had to get a physical.

What’s behind the $38,398 price tag for a single dose of the drug to treat prostate cancer? A mixture of unrelenting drug price increases and hospital system consolidation.

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?

Abbott Laboratories is building a new infant-formula manufacturing plant after the product shortage of the past year revealed gaps in U.S. production capacity.

The recall, issued on Oct. 14, includes the brands Similac and Pedialyte Electrolyte Solution

Holley’s mission is to bring awareness to all disabilities with the message, “Our Ability is STRONGER than our dis-Ability.”

Select Similac products are part of a new recall from Abbott Nutrition.

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.